These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3545429)

  • 1. A morphologic study of childhood lymphoma of the diffuse "histiocytic" type. The Pediatric Oncology Group experience.
    Nathwani BN; Griffith RC; Kelly DR; Shuster JJ; Hvizdala E; Sullivan MP; Murphy SB; Berard CW
    Cancer; 1987 Mar; 59(6):1138-42. PubMed ID: 3545429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of the Lukes-Collins classification in identifying subsets of diffuse histiocytic lymphoma responsive to chemotherapy.
    Newcomer LN; Nerenberg MI; Cadman EC; Waldron JA; Farber LR; Bertino JR
    Cancer; 1982 Aug; 50(3):439-43. PubMed ID: 7046901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant "histiocytic" lymphoma in childhood.
    Koh SJ; Vargas GF; Caces JN; Johnson WW
    Am J Clin Pathol; 1980 Oct; 74(4):417-26. PubMed ID: 6999887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of histology and immunophenotype in childhood diffuse large cell lymphoma.
    Hutchison RE; Fairclough DL; Holt H; Pui CH; Sandlund JT; Berard CW
    Am J Clin Pathol; 1991 Jun; 95(6):787-93. PubMed ID: 2042587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcategories of histiocytic lymphoma: associations with survival and reproducibility of classification. The Southeastern Cancer Study Group experience.
    Whitcomb CC; Cousar JB; Flint A; Crissman JD; Bartolucci AA; Durant JR; Gams RA; Collins RD; Byrne GE
    Cancer; 1981 Dec; 48(11):2464-74. PubMed ID: 7028247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lukes and Collins classification of non-Hodgkin's lymphomas. I. A histological reappraisal of 301 cases.
    Alavaikko M; Aine R
    Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):241-9. PubMed ID: 7124395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification.
    Diebold J; Anderson JR; Armitage JO; Connors JM; Maclennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Weisenburger DD
    Leuk Lymphoma; 2002 Jan; 43(1):97-104. PubMed ID: 11908742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of morphologic subdivision in diffuse large cell lymphoma.
    Kwak LW; Wilson M; Weiss LM; Horning SJ; Warnke RA; Dorfman RF
    Cancer; 1991 Nov; 68(9):1988-93. PubMed ID: 1913547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
    Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
    Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lukes and Collins classification of non-Hodgkin's lymphomas. 2. A survival study of 301 patients.
    Aine R; Alavaikko M; Kataja M
    Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):251-6. PubMed ID: 7124396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group.
    Nathwani BN; Dixon DO; Jones SE; Hartsock RJ; Rebuck JW; Byrne GE; Sheehan WW; Kim H; Coltman CA; Rappaport H
    Blood; 1982 Nov; 60(5):1068-74. PubMed ID: 6751435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
    Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
    Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A morphologic study of childhood lymphoma of the lymphoblastic type. The pediatric Oncology Group experience.
    Griffith RC; Kelly DR; Nathwani BN; Shuster JJ; Murphy SB; Hvizdala E; Sullivan MP; Berard CW
    Cancer; 1987 Mar; 59(6):1126-31. PubMed ID: 3815288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma.
    Strauchen JA; Young RC; DeVita VT; Anderson T; Fantone JC; Berard CW
    N Engl J Med; 1978 Dec; 299(25):1382-7. PubMed ID: 362206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic involvement by aggressive malignant lymphomas of B-cell and T-cell types. A morphologic and immunophenotypic study.
    Stroup RM; Burke JS; Sheibani K; Ben-Ezra J; Brownell M; Winberg CD
    Cancer; 1992 Jan; 69(2):413-20. PubMed ID: 1728369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement.
    Trump DL; Mann RB
    Cancer; 1982 Jul; 50(2):277-82. PubMed ID: 7044520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the Lukes and Collins classification in patient treated with COMLA.
    Sweet DL; Collins RD; Stein RS; Ultmann JE
    Cancer Treat Rep; 1982 May; 66(5):1107-11. PubMed ID: 7044531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.